Introduction
“Give every individual the right amount of exercise, not too little and not too much”
– Hippocrates
Physical activity has long been tied to good health. Hippocrates was guided by his theory of balanced humors to advocate that absolutely everyone, young or old, needs exercise -- but not too much. A landmark 1953 study noted that drivers of public trolleys in London had twice as many acute coronary syndromes as did conductors of the same trolleys; the only notable difference: conductors walked as they collected tickets, while drivers sat.1, 2 In the decades since this seminal epidemiological observation, nearly every aspect of human physiology has been demonstrated to benefit from exercise, ranging from lung and cardiac function to cognition and aging (Figure 1). The same decades, however, have witnessed a dramatic sedentarization of the US population (despite the newfound popularity of recreational exercise). Today, the consequences of sedentary lifestyles, synergizing with dramatic increases in caloric intake, are ubiquitous and devastating.
Figure 1.
The many long-term benefits of regular endurance exercise.
Exercise is a fundamental component of the human condition. Humans are the only primates capable of sustained long-distance running, and this behavior likely significantly shaped the evolutionary departure of humans from other primates.3 For example, the need for heat dissipation during prolonged physical activity likely favored loss of body hair and the proliferation of sweat glands, thereby considerably altering the human form.4, 5 Endurance exercise is thus not only good for us, but in fact is part of what defines us. Not surprisingly, the study of exercise, including its mechanics, physiology, and health benefits, has long garnered fascination. Over the last decade, new molecular techniques have ushered a new era of exercise research, focused on understanding fundamental mechanisms. The wealth of new information is staggering. The objective of this review is to provide physicians with key examples of insights gained from this body of work, and to highlight new directions in exercise research that these new molecular tools have opened. The review is illustrative, rather than comprehensive, and we apologize for the omission of many fascinating studies (for some comprehensive reviews, see refs 6–8). The focus will be on endurance exercise and the increasing use of genetically modified mice as a tool to uncover molecular mechanisms of adaptation to endurance exercise.
What goes on inside the muscle
Fiber adaptations: white meat and dark meat
Exercise begins in the contracting muscle. Mechanisms of actin/myosin contraction, of calcium handling, and of neuromotor control have been well studied for a long time. More recently, with new tools in hand, attention has been paid to how muscle adapts to endurance activity. Skeletal muscle is composed of syncitia of thousands of cells, often stretching from tendon to tendon. Different fibers are faced with contrasting tasks, ranging from low-amplitude and repetitive endeavors, like ambulation and maintenance of posture, to sudden bursts of high-amplitude work, such as heavy lifting. Fibers are typically specialized to these tasks (Figure 2).9 Fiber types have classically been defined by their myosin heavy chain content, but modern molecular tools have uncovered a high complexity and heterogeneity of fiber types, which sometimes differs between humans and rodents, and which renders simple classification difficult. In broad terms, three major types of human skeletal muscle are type I (slow) oxidative, type IIa (fast) oxidative, and type IIx (fast) glycolytic. The relative amount of these fibers differs between individuals and in various disease states. For example, congestive heart failure and type II diabetes are associated with a lower proportion of type I fibers.10, 11
Figure 2.
Simplified overview of muscle fiber types. Muscle consists of cellular syncitia called fibers, which often span from tendon to tendon. Individual fibers have specific attributes, dictated by their myofibrillar and metabolic makeup, and ranging from fast and glycolytic, to slow and mostly oxidative. Most human muscles comprise mixtures of fiber types. Exercise and other stimuli can alter fiber type profiles. Endurance exercise promotes conversion to more oxidative/slow fiber phenotype, a process that requires activation of various programs of gene expression (see Figure 3).
Glycolytic fibers contain myofibrillar proteins that are capable of generating rapid and powerful work, amenable to sudden high-intensity work. This comes at the expense of high calcium fluxes and less efficient use of ATP. In contrast, oxidative fibers contain a more energetically efficient myofibrillar apparatus, more amenable to prolonged activity. Oxidative fibers are also highly vascular, and contain enriched mitochondrial networks, allowing for complete oxidation of fatty acids and other fuels, a much more efficient way to generate ATP than anaerobic glycolysis. High concentrations of myoglobin and cytochromes redden these fibers, hence the term “red fibers”. Human muscles mostly contain mixtures of fiber types. In certain organisms, fiber types can segregate. Terrestial fowl, for example, have wings of glycolytic fibers and hindlimbs of oxidative fibers, commonly recognized as ‘white meat’ and ‘dark meat’.
Skeletal muscle gains much of its fiber heterogeneity during development. Nevertheless, adult muscle retains significant plasticity.9 Endurance activity can significantly expand mitochondrial and vascular networks and in part change the myofibrillar content in muscle fibers (Figure 2). How does this process occur? The last 10 years have begun to answer this question at the molecular level (Figure 3). Much of this work has relied on the study of genetically modified mice (e.g., Figure 4). Rodents are natural-born endurance exercisers: provided with in-cage running wheels, most mice will voluntarily run 5–8 kilometers per night. Although this level of exercise does not precisely model the human condition, the ability to model endurance exercise in an organism amenable to genetic manipulation has proven invaluable. Conceptually, the adaptation process can be divided into mechanisms that sense endurance activity, and mechanisms that carry out the desired adaptations (Figure 3).
Figure 3.
Modular signaling pathways that underpin muscular adaptations to endurance exercise. Exercise triggers patterns of innervation and metabolic perturbations that are sensed by skeletal muscle. These inputs activate intermediate signaling mechanisms, including calcium-mediated signaling and metabolic sensing pathways like AMPK and SIRT. These signals ultimately impinge on groups of transcription factors, each of which controls a broad biological module, such as mitochondrial biogenesis or control of fatty acid transport and metabolism. Adaptations to exercise can thus be regulated in a modular fashion.
Figure 4.
Mighty mice. Left: sample images of skinned mice from control (top) and mice genetically engineered to over-express PGC-1beta in skeletal myotubes. High levels of myoglobin and mitochondria render the muscles red (bottom). Myofibers have high oxidative capacity, and the mice are capable of running further and harder on treadmill endurance tests. Right: other known genetic mouse models with increased mitochondrial capacity in skeletal muscle. mTg: myotube-specific over-expression via transgenesis. mKO: myotubes-specific deletion (knockout) of the indicated gene. KO: total-body knockout of the indicated gene.
How does muscle sense exercise activity? Nerves and energy
Key molecular sensors of exercise include the calcium oscillations and other signaling cascades activated by neural stimulation, and the profoundly altered metabolic state of contracting myofibers.
Stimulation of muscle by motor nerves generates cytosolic calcium transients that are detected by various intracellular pathways, including those regulated by the calcium/calmodulin-modulated phosphatase (calcineurin) and kinase (CaMK). Continuous low-amplitude transients, typical of endurance activity, activate calcineurin. Transgenic over-expression of calcineurin in skeletal muscle of mice promotes the formation of slow red fibers.18 Conversely, genetic deletion of calcineurin or treatment with calcineurin inhibitors has the opposing effect, blocking exercise-induced adaptations.31 CaMK is likely another decoder of calcium transients.32 CaMKII is the predominant isoform in skeletal muscle, but experiments with transgenic expression of a constitutively active CaMKIV isoform showed that CaMK can promote the formation of slow red fibers.29 Conversely, mice with decreased CAMKII activity have lower expression of slow genes.33 Sensing of calcium transients thus appears to be a critical transducer of motor nerve activity.
Sympathetic stimulation also contributes to muscle adaptations. β2 adrenergic receptors predominate in skeletal muscle, and transduce via canonical and alternative G-protein signaling to cyclic adenosine monophosphate (cAMP), protein kinase A (PKA), and exchange protein directly activated by cAMP (EPAC), ultimately affecting numerous cellular pathways. Among these, the p38 MAPK system may predominate in muscle adaptations: genetic deletion of p38 isoforms in mouse skeletal muscle blocks many adaptations to endurance exercise34, while genetic activation of p38 increases mitochondrial markers.30 G-protein-mediated sympathetic stimulation crosstalks with the CaMK system in complex ways35, and these signals are likely integrated in skeletal muscle. The MAPK system also responds to, and likely also integrates, endurance exercise-induced increases in reactive oxygen species (ROS) generated by both the increased electron transport chain activity and activated NADPH oxidase.
Endurance exercise also elicits profound metabolic changes that can be sensed to trigger long-term adaptations. A key sensor is the AMP-activated protein kinase (AMPK). AMPK integrates multiple signals that alert to cellular energetic insufficiency, such as elevated AMP/ATP ratios. Once activated, AMPK triggers metabolic pathways that can compensate for this deficiency, such as mitochondrial biogenesis, while inhibiting anabolic pathways that consume ATP. Mice engineered to lack AMPK activity in skeletal muscle run poorly and lack nearly half their mitochondrial content.36 Conversely, mice engineered to express an activated form of AMPK have higher mitochondrial content, more β-oxidation, and are resistant to fatigue.37, 38 Other metabolic sensors are less conclusively implicated in exercise adaptations, but likely also play a role, including the aging-associated sirtuin (SIRT) family of proteins. SIRTs are deacetylating enzymes that require NAD and sense NAD/NADH ratios, which reflect cellular redox state. The NAD/NADH ratio, and thus likely SIRT activity, increases significantly with exhaustive exercise.39 SIRT activity is also enhanced by AMPK, thus linking these two pathways.39
Exercise-induced hypoxia or ischemia has also long been advocated as a potential mediator of muscle adaptation to endurance exercise. Acute exercise reduces the partial pressure of oxygen in the vicinity of myoglobin to <4mmHg (<1/40th of atmospheric)40, which is sufficiently low to activate the critical hypoxia-sensor hypoxia-inducible factor-1α (HIF-1α). However, it is not clear that this level of hypoxia is achieved in the nucleus, where HIF-1α resides. Moreover, mice genetically modified to lack HIF-1α in muscle have higher, rather than lower, oxidative capacity.41, 42 Conversely, people living at higher altitudes, where oxygen tension is low, tend to have less oxidative muscle, rather than more. It thus remains uncertain if hypoxia mediates pro-oxidative adaptations to endurance exercise in muscle.
In summary, nerve stimulation and calcium signaling, and metabolic changes that occur in the contracting myofiber, are likely the key instigators of adaptations to exercise in muscle. These signals vary dramatically in both quality and quantity in response to exercise of different types, intensities, and durations. This last point poses a challenge to exercise research. The effects of exercise can differ widely depending on exercise type, dose, intensity, or frequency, and inter-individual adaptations to exercise also vary widely. Thus a key advantage of studying rodent models, i.e. their genetic and phenotypic homogeneity, can also be a drawback. Experimental exercise regimens are not fully standardized, and comparing studies can sometimes be difficult. It is also difficult to scale rodent exercise to human exercise, e.g., how much does 5 kms of voluntary running overnight by a 40g mouse equate to in human terms? Nevertheless, the ability to model endurance exercise in an organism that is amenable to genetic manipulation continues to prove invaluable. How the complex inputs of endurance exercise are integrated thus remains incompletely understood. Metabolic signaling in particular is likely to be a prominent focus of research in the forthcoming years.
How does muscle reprogram in response to exercise? Plug-and-play
The signals discussed above impinge on a number of regulators of gene expression that reprogram myofibers from glycolytic to more oxidative fibers. Two important concepts guide this process. First, these regulating factors typically control broad programs. The transcriptional regulators peroxisome proliferator-activated receptor gamma coactivator 1-α (PGC-1α) and PGC-1β, for example, can activate an entire program of mitochondrial biogenesis, including all components of the electron transport chain, the TCA cycle, and fatty acid β-oxidation.43 Simple transgenic expression of PGC-1 in skeletal myofibers dramatically increases mitochondrial content, yielding mice with improved endurance exercise capacity and peak oxygen uptake (Figure 4).12, 14 Conversely, deletion of both PGC-1 isoforms in muscle drastically reduces oxidative capacity.44, 45 Most signaling pathways described above, including calcineurin, p38 MAPK, adrenergic signaling, and SIRT proteins, impinge on the PGC-1s, and do so in a variety of molecular ways, including protein phosphorylation and deacetylation, and induction of gene expression.46 The PGC-1s are thus potent nodal points of gene regulation used by myofibers to coordinate adaptations to exercise. A number of other such regulators exist (e.g., Figure 4).
A second important concept is that these nodal points regulate defined and modular programs (Figure 3). For example, the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) modulates the use of fatty acid as a fuel by regulating the specific subset of genes encoding rate-limiting enzymes for fatty acid transport and oxidation.47 Similarly, a small set of transcription factors including nuclear respiratory factor (NRF-1), NRF-2, and estrogen-related receptor α (ERRα), control the complex generation of new mitochondria, including control of the replication and expression of the mitochondrial genome.48 The specific makeup of the myofibrillar apparatus, on the other hand, appears to be regulated primarily by myocyte enhancer factor-2 (MEF2) and nuclear factor of activated T-cells (NFAT) transcription factors, modified in turn by a number of histone deacetylases (HDACs).20 Any these independent programs can be coordinately modulated by the PGC-1s or other coordinating agents. Cellular reprogramming can thus occur in a modular fashion, with a relatively simple interface between input and output, analogous to plug-and-play.
An important implication of this modular regulatory concept is that modules can be activated independently, even if there is often significant crosstalk between them. For example, genetic deletion of both PGC-1α and β in murine muscle leaves the myofibers metabolically crippled, but has almost no effect on the myofibrillar content of the myofibers.44, 45 The myofibrillar and metabolic responses to endurance exercise thus appear genetically dissociable and are likely regulated by exercise differently. In a highly simplified schema, it can be suggested that calcium signaling, occurring via calcineurin and CAMKII, predominantly affects myofibrillar adaptations, while metabolic sensing, via AMPK and other sensors, predominantly affects mitochondrial and other metabolic adaptations.6, 7, 49, 50
In summary, nerve activity and metabolic changes are transduced to a cadre of transcriptional regulators that modularly translate this information into specific muscle adaptations. Other forms of modulation are superimposed on these gene regulatory pathways. Recent exciting additions include epigenetic modifications, and micro RNAs (miRNAs). Methylation of DNA had long been thought to be a slow and meta-stable way to regulate gene expression, sometimes even allowing transmission of information across generations. It is now clear, however, that even a single bout of exercise can dramatically alter the methylation of certain genes, including PGC-1α.51 This surprising finding unveils entirely new potential mechanisms of exercise adaptations. Similarly, the recent discovery of miRNAs has also opened new avenues of potential regulation. miRNAs are short RNAs that potently inhibit gene expression by binding to target mRNAs and causing their degradation or blocking their translation. Skeletal muscle expresses a number of miRNAs, dubbed myomiRs. For example, miRNAs 208b and 499 are co-expressed with slow MHC genes and act to inhibit expression of genes specific to fast myofibers, thus reinforcing the slow program.52 A number of miRNAs are regulated by exercise53, but their role in exercise adaptations remains unknown, and appropriate mouse models have yet to be generated. Some miRNAs are also secreted into the circulation, raising the enticing notion that they may act as endocrine signals.54 The study of miRNAs as potential mediators of adaptations to exercise remains in its infancy, but holds great promise.
Beyond fiber types: other important ways that exercise changes skeletal muscle
Discussions of metabolic adaptations to endurance exercise are often limited to mitochondrial biogenesis, but mitochondrial reprogramming is likely much more complex. Mitochondria are traditionally portrayed as static, oval, organelles. Recent work has challenged this view and revealed mitochondria as forming a large and dynamic reticular network, constantly fusing and breaking apart in a highly coordinated manner.55–57 These fusion/fission events appear imperative for normal mitochondrial function. For example, they allow for constant redistribution of both genetic and biochemical components between separate mitochondria, a process that is somehow used to segregate dysfunctional mitochondrial components and to remove them from the network via autophagy (discussed below).58 The regulation of mitochondrial fusion is controlled by mitofusins (Mfn1 and Mfn2) on the outer mitochondrial membrane and optic atrophy type 1 (Opa1) on the inner mitochondrial membrane, while fission is regulated by dynamin-related protein (Drp1) and Fission 1 (Fis1).56 Exercise induces the expression of most of these genes in both human and rodent muscle.59–61 PGC-1α induces the expression both Mfn1 and Mfn2 via activation of ERRα.60 Deletion of both Mfn1 and Mfn2 in mouse skeletal muscle leads to profound lactic acidosis in response to exercise.62 These observations thus suggest that mitochondria in muscle are not static objects, and that mitochondrial dynamics play an important role in exercise adaptations. The specifics of that role remain poorly understood.
Autophagy (Greek for “self-eating”) is a process by which cells selectively move damaged organelles like mitochondria to the lysosome for subsequent degradation. This quality control process is critical for maintaining tissue integrity.63 The process also appears important for adaptations to exercise. Exercise strongly and rapidly induces autophagy in skeletal muscle and numerous other tissues.64–66 Moreover, genetically modified mice that lack stimulus-induced autophagy have drastically reduced treadmill running capacity, suggesting that autophagy is important for endurance capacity. On the other hand, inappropriate autophagy in muscle can be pathological, as seen after treating mice with doxorubicin, and in this case exercise is protective.67 The interplay between exercise and autophagy in muscle is thus complex. Mitochondria are also not the only organelles that respond to exercise. Exercise, for example, also activates the unfolded protein response (UPR) in the sarcoplasmic reticulum. Mice that lack activating transcription factor 6 (ATF6), a key regulator of the UPR, exhibit severe exercise intolerance.68 In sum, burgeoning data with novel mouse models suggest that exercise helps to maintain homeostasis of multiple organelles in skeletal muscle, with likely important implications for the health of the whole organism.
Exercise also promotes neovascularization in skeletal muscle. Exercise-induced angiogenesis (EIA) is a physiologic process, in contrast to most post-developmental angiogenesis (e.g., neoplasms, retinal diseases). Exercise also remains the most efficacious intervention for peripheral artery disease (PAD). Understanding EIA could thus inform novel approaches for the treatment of PAD. The prevailing paradigm had been until recently that metabolic demands created by exercising muscle cause a supply/demand mismatch, leading to activation of ischemic sensors like AMPK and HIF-1α. Recent data with genetically modified mice, however, do not support this notion. Mice lacking AMPK activity in skeletal muscle have intact EIA69, and mice lacking HIF-1α in skeletal muscle have more, rather than fewer, microvessels42. On the other hand, mice lacking PGC-1α in skeletal muscle lack the capacity for EIA70 (although, interestingly, not for exercise-induced mitochondrial biogenesis71, 72) Conversely, mice transgenically over-expressing PGC-1 in skeletal muscle have dramatic increases in microvascular density, and are protected in a hindlimb ischemia model of PAD. β-adrenergic and other signals induce PGC-1α in skeletal muscle, and PGC-1α directly activates expression of the canonical angiogenic factor VEGF in a HIF-independent fashion.73 Physiological angiogenesis in muscle is thus likely triggered more preemptively by nerve activity than reactively by ischemia.
Stepping outside the muscle -- Is skeletal muscle an endocrine organ?
Experiments over the last decade have made it increasingly clear that, in response to exercise, muscle secretes into the circulation sometimes copious amounts of factors, now known as myokines.74 In retrospect, this is perhaps not surprising: muscle is the largest organ in the body, and can command up to 80% of cardiac output during exercise. Muscle is thus ideally suited to disseminate blood-borne substances in response to exercise.
The interleukin IL-6 was one of the earliest discovered myokines, and remains one of the most studied (Figure 5).75 Muscle contraction and exercise increase the expression of IL-6 in muscle and levels of IL-6 in the circulation by as much as 100-fold. In an autocrine and paracrine fashion, IL-6 increases glucose uptake and fatty acid oxidation in muscle, thus facilitating fuel consumption locally.76 At the same time, in an endocrine fashion, IL-6 stimulates lipolysis in adipose tissue and gluconeogenesis in the liver, both of which increase fuel delivery back to the muscle. Recently, IL-6 secreted by muscle has also been shown to crosstalk with the gut and pancreas to regulate insulin homeostasis77. IL-6 stimulates the secretion of glucagon-like peptide-1 (GLP-1) in intestinal L-cells and pancreatic α cells. GLP-1, in turn, potentiates insulin secretion from pancreatic β cells. IL-6 −/− mice fail to induce GLP-1 during exercise, and develop mature onset obesity and glucose intolerance.78 Conversely, exogenous IL-6 improves insulin sensitivity, but not in GLP-1 −/− mice.77 This IL-6/GLP-1 axis thus likely mediates the enhanced insulin action seen in the immediate post-exercise period. Interestingly, GLP-1 may also contribute to cognitive effects of exercise: GLP-1 KO mice have learning deficits79, while GLP-1 agonists improve memory tasks in mice80 (see below for discussion of cognitive effects of exercise). In sum, muscle-derived IL-6 appears to help integrate the entire organism response to the needs of exercising muscle (Figure 5). Other interleukins and traditional inflammatory cytokines, including IL8 and IL15, also likely double as exercise-induced myokines, though their functions are less clear.21, 28, 75
Figure 5.
Muscle as an endocrine organ. Exercise triggers the secretion from muscle of numerous factors that impinge on systemic function. See text for details.
Irisin is a different potential myokine that has received much attention recently. Irisin is a soluble cleavage product of fibronectin type III domain containing 5 ( FNDC5), a transmembrane protein found in myocytes.81 Release of irisin, acting via an as yet unknown receptor, “browns” nearby white fat cells that are interdigitated between muscle fibers. The uncoupler UCP1 and other markers of brown fat are induced in these cells, leading to a futile cycle of uncoupled mitochondrial respiration, and dissipation of heat. Paracrine release of irisin thus promotes consumption of fuels. Consistent with this, exogenous administration of irisin ameliorates diet-induced obesity in mice.81 Circulating levels of irisin correlate with endurance capacity82, and increase during exercise81 (though some controversy exists on this point83), but the endocrine effects of irisin remain uncertain. It is also unclear, but interesting, why exercise should promote wastage of fuel in adjacent brown fat cells, when energy efficiency would seem preferable when exercising. One possibility is that irisin is in fact primarily part of a shivering program to produce heat, rather than an exercising program. Interestingly, irisin is also induced by myostatin, another molecule secreted from myocytes.84 Myostatin inhibits muscle growth, and has received wide attention as a potential target to preserve muscle mass. Deletion of myostatin in mice leads to secretion of irisin and browning of white fat.84
Numerous other myokines exist that can have profound effects on systemic metabolism. FGF21 is secreted from muscle in response to mitochondrial dysfunction or anabolic signals and protects from obesity and diabetes, likely in part by inducing a hypermetabolic state.85, 86 Myonectin secretion increases in response to numerous metabolic perturbations, including exercise, and modulates systemic handling of fatty acids.87 Yet other myokines, like VEGF and other angiogenic factors (see above), may function primarily as paracrine factors. Exercise for example liberates membrane-bound neuregulin, freeing it to both stabilize neuromuscular junctions and promote glucose uptake in myocytes.88 Similarly, the neurotrophin Brain Derived Neurotrophic Factor (BDNF) and the interleukin-like LIF are induced by exercise and may promote fatty acid oxidation in muscle.89, 90 BDNF may additionally contribute to muscle-brain crosstalk in exercise (see below).
Signals emanating from muscle also need not be polypeptides. Exercise significantly alters circulating levels of numerous metabolites, including for example lactate. Such metabolites can alter systemic metabolism in important ways. A classic example is the Cori cycle, in which lactate secreted from exercising muscle is recycled by the liver to glucose that is then returned as fuel to muscle. The recent advent of powerful techniques for high-throughput measurements of metabolites (metabolomics) is significantly expanding the list of known metabolites altered by exercise.91 Understanding their role, if any, in organ inter-dependence is only beginning. Many metabolites can affect cellular signaling directly, often via ligand-specific G-protein couple receptors (GPRs). Examples include succinate and GPR9192, and the recognition of lactate by GPR8193, and other GPR/metabolite combinations are likely to be discovered. It is likely that at least some of these metabolites serve as myokine-like signaling molecules. This aspect of exercise signaling is in its infancy and especially promising.
In sum, exercise (and other metabolic stimuli) triggers from muscle the secretion of proteins and small molecules that integrate systemic adaptations to the demands of exercise. The study of these factors is still in an early discovery phase. Skeletal muscle may well be a large under-appreciated endocrine organ.
Exercise and the heart
The effects of exercise on the heart have been reviewed recently in Circulation and will only briefly be covered here.94 The adult human heart retains considerable plasticity. This is most evident in the maladaptive cardiac remodeling that often follows myocardial infarction, chronic hypertension, and other cardiac insults. Efforts to impede this pathologic remodeling, via blockade of the adrenergic and angiotensin systems, form the mainstay of current heart failure management. Despite these treatments, however, the 5-year mortality of patients with heart failure remains >30%. New and qualitatively different therapeutic approaches are clearly needed.
Endurance exercise can induce cardiac mass by as much as 20%.95 This physiological remodeling differs significantly from the pathologic remodeling noted above.96 In model organisms, exercise similarly induces cardiac hypertrophy, and improves outcomes after experimental myocardial infarct and other cardiac insults. Understanding these physiological remodeling pathways may thus afford therapeutic opportunities that differ from the existing paradigm of blocking neurohormonal activation. Many effects of exercise on the heart are indirect, including reductions in BMI and improvements in insulin sensitivity. Other effects, however, are clearly direct. Insulin-like Growth Factor-1 (IGF-1) engages the IGF-1 receptor on cardiomyocytes and activates the intracellular PI3K/Akt pathway. This leads to inhibition of apoptosis, improvements in metabolism and calcium handling, and activation of the mTOR-dependent hypertrophic pathway.97–100 As with skeletal muscle, concomitant adrenergic input is likely also critical for exercise-induced cardiac adaptations, in this case via β3 receptors and increased nitric oxide (NO) bioavailability.101 Other pro-physiological hypertrophy mechanisms likely exist.
One of the exciting developments in cardiac research in the last decade has been the realization that the adult heart harbors at least the potential for endogenous regeneration. Adult newts and zebrafish, and newborn mice, can regenerate seemingly normal hearts after apical resection.102–104 In humans, calculations based on the incorporation of ambient radioactivity generated in the 1950’s by above-ground testing of nuclear bombs has conclusively demonstrated that human cardiomyocytes can turn over, albeit slowly.105 It remains controversial whether this turnover stems mostly from the replication of existing cardiomyocytes or from resident or circulating stem cells. In either case, data are emerging to suggest that exercise may activate this process. Endurance exercise in rodents induces measurable replication of cardiomyocytes.106 Transcriptional profiling of exercising rodent hearts revealed that endurance exercise represses expression of the transcription factor CCAT-enhancer binding protein (C/EBPβ). Haploinsufficiency of C/EBPβ in mice led to physiological cardiac hypertrophy and cardiomyocyte proliferation, thus mimicking some effects of exercise on the heart. Akt inhibits C/EBPβ, and may thus promote cardiomyocyte proliferation.106 Other Akt-dependent pathways likely exist.107 The mechanisms underlying these observations are being studied intensively.
A longstanding and often controversial debate exists over the ideal amount of exercise needed for cardiac protection, and the possibility that too much exercise may have ill-effects.108, 109 A link between strenuous exercise and sudden death is well-established, but can only partly be explained by the well-known high prevalence of idiopathic hypertrophic cardiomyopathy in this population.110 Strenuous exercise may cause disproportionate adaptations in the right ventricle (RV), which have been postulated to predispose to arrhythmias, most commonly atrial fibrillation.111, 112 12 weeks of aggressive exhaustive exercise training in rats led to RV enlargement, diastolic dysfunction, and fibrosis, and increased susceptibility to triggered VT.113 The changes were likely caused by pathologic angiotensin II (ATII) activation, because angiotensin converting enzymes inhibitors (ACEIs) reversed the phenotype114, but the mechanisms of cardiotoxicity by strenuous exercise remain unclear. These studies highlight a number of important issues: 1) the effects of exercise differ depending on exercise type, intensity, or frequency; 2) the appropriate “dose” of endurance exercise in humans is likely variable, because inter-individual responses to exercise vary widely; 3) the “dose” that maximally confers cardiovascular protection likely differs from that which maximally confer cardiovascular fitness; 4) rodents provide powerful tools with which to probe the molecular mechanisms of exercise adaptations, but they are poor models to ascertain the optimal “dose” of exercise in humans, because specific rodent and human exercise regimens are difficult to compare (i.e., poor scalability); and 5) the Hippocratic instruction of tempered exercise likely holds true today as it did 2500 years ago.
Exercise and the brain – active body and mind
There is little doubt that exercise improves mental health. Physical activity correlates well with mental well being, especially in old age. Exercise significantly counteracts at least moderate depression, and can prevent loss of memory. Indeed, mental well-being post-MI is a strong predictor of outcomes, and improvements in mental health may well explain a significant part of why physical activity is so beneficial to cardiovascular health.
Early and exciting inroads are being made into understanding the molecular mechanisms that underlie these neuronal benefits of exercise. One focus has been on a small roster of secreted neurotrophic factors, including BDNF and VGF. BDNF is a well-studied neurotrophin, thought to be critical for learning and memory. Exercise stimulates BDNF expression in the hippocampus, the seat of learning, and raises levels of BDNF in venous return from the brain in humans.115, 116 Exercise has been known to stimulate neurogenesis in the adult hippocampus117, and the increases in hippocampal size seen in exercising humans correlates with exercise capacity (VO2max) and circulating BDNF118. Neutralizing BDNF, either with blocking antibodies119 or by genetic deletion in BDNF +/− heterozygote animals120, prevents the ability of exercise to improve learning. BDNF likely mediates these responses to exercise by modulating neuronal and axonal plasticity, and may do so in part via activating pro-energetic pathways including PGC-1α and mitochondrial biogenesis.121, 122 BDNF is also likely modulated by other neurotrophic factors, including IGF-1, which is also significantly induced in the hippocampus by exercise.123
Exercise also ameliorates major depression in humans, and produces antidepressant effects in rodent models. Interestingly, transcriptional profiles of rodent hippocampus after exercise and after treatment with serotinergic antidepressants yield similar results, suggesting similar mechanisms of action124. The presence of the peptide VGF increases in the hippocampus during exercise, and intracerebroventricular infusions of VGF produce antidepressant-like effects in mouse and rat behavioral models125. Conversely, antidepressant responsiveness to exercise in the same models was blocked in heterozygous VGF +/− mice125. VGF is regulated by BDNF, expression of which is also low in depression. Like BDNF, VGF likely modulates synaptic plasticity in response to exercise125. Other factors also exist to mediate the anti-depressant effects of exercise. The macrophage migration inhibitory factor (MIF), for example, likely contributes to activation of BDNF during exercise, and MIF −/− mice have a blunted antidepressant response to exercise126. Together, these small neurotrophic factors thus appear to mediate important beneficial neurologic changes in response to exercise.
The notion that circulating factors can impact neurogenesis and cognitive function was also recently elegantly demonstrated in mice by the use of heterochronic parabiosis, i.e. the surgical creation of adult artificially conjoined twins that share blood-borne factors127. Young-old parabiotic pairs were generated, and the young animals in these pairs displayed impaired learning and memory, and decreased synaptic plasticity, suggesting the existence of blood-borne factors derived from the older animal in these pairs that impair cognitive function127. The authors identify one such factor, eotaxin (also known as chemokine, cc motif ligand 11 (CCL11)), and show that artificially increasing peripheral eotaxin levels in young mice impairs learning and memory. Interestingly, eotaxin levels are decreased by exercise.128
The neurological benefits of exercise are not limited to depression and memory. Exercise also benefits neurodegenerative illnesses like Parkinson disease and Alzheimer’s disease, and this can be recapitulated in rodent models.129, 130 Mice lacking one copy of BDNF fail to benefit from exercise, again implicating this factor in exercise-induced neuroplasticity131. A genetic model of spinocerebellar ataxia (SCA), caused by a polyglutamine expansion in the Ataxin-1 protein, is also markedly improved by exercise132. Again, a neurotrophic factor induced by exercise is implicated: epidermal growth factor (EGF). A downstream effector of EGF, Capicua (Cic), interacts directly with ataxin and is strongly inhibited by exercise. Genetic reduction of Cic in Cic +/− heterozygote mice rescues multiple abnormal phenotypes in the SCA mouse model, thus mimicking the effects of exercise132.
Lastly, although there have been great inroads in recent years in the understanding of neural networks that regulate appetite for food, much less has been done to ask the same question of exercise: what regulates appetite for exercise? Different rodent strains have different appetites for voluntary exercise, and rodents can be selectively bred for high versus low voluntary physical activity, indicating the existence of a strong genetic component.133, 134 Genetic quantitative trait loci that track with these differences can in fact be mapped135, but their function remains unknown. Importantly, subsequent studies reveal few differences in skeletal muscle composition between these selected mouse cohorts136, 137, indicating that central networks likely regulate motivation for exercise. Initial experiments, mostly pharmacological, implicate the dopaminergic system138, underscoring links to movement disorders like Parkinson’s disease. Definitive genetic experiments in mice, akin to those performed to evaluate the neurobiology of food satiety, have not yet been reported.
Spontaneous physical activity (e.g. fidgeting, pacing, and activities of daily living) differs from volitional exercise (e.g. sports), but may have equal health benefits. The hypothalamic neuropeptide orexin has been strongly implicated in regulation of spontaneous physical activity.139 Orexinogenic neurons impinge on dopaminergic neurons, and injection of orexin into the lateral hypothalamus of murine brains stimulates spontaneous activity. Conversely, ablation of orexinogenic regions of the thalamus, or genetic deletion of orexin, reduces spontaneous physical activity.140 Orexin is also implicated in the regulation of food satiety, underscoring the strong overlap between the appetites for food and exercise.139 Complex interplay also exists with mood and reward circuitry, and with circadian rhythms. This exciting avenue of research is still in its early phase.
In summary, complex mechanisms underpin the dramatic cognitive and neural benefits of exercise. A number of exercise-induced neurotrophic factors are providing the initial molecular clues to decipher these mechanisms.
Exercise and Aging
Exercise capacity predicts longevity141, and physical fitness is one of the best predictors of health in elderly individuals142. For instance, a study of 538 aged runners and 423 age-matched controls found that only 15% of the runners died over 21 years, compared to 34% in the control group143. Controlled experiments to prove causality are of course difficult in humans, but animal experiments also have strongly supported the conclusion that exercise prolongs life. Forcing rodents to exercise prolongs their average longevity and improves their aged health status.144, 145 Evolution-in-the-lab experiments, in which rodents with higher exercise capacity were selected and interbred over numerous generations, revealed that longevity was co-selected with exercise capacity.133 Exercise is thus linked to long life both in animal models and in man.
How does exercise prolong life? Does it do so by individually averting each of the illnesses of aging, or does it have a more general and fundamental anti-aging power? The question is difficult to answer in part because the process of aging remains poorly understood. A number of theories of aging exist. The mitochondrial theory of aging, borne of the earlier “free radical theory of aging” proposed in 1956 by Denham Harman146, posits that unstable free radicals produced by mitochondria are an obligatory byproduct of aerobic life. These radicals damage biomolecules, especially mtDNA, leading to progressive mitochondrial dysfunction, worsening free radical generation, and thus a vicious cycle of oxidative damage that ultimately limits mammalian lifespan147–152. Accumulation of oxidative damage to DNA, proteins, and membranes can be seen in aged tissues across phylogeny, including humans. Recent experiments in genetically modified mice have supported the mitochondrial/free radical theory of aging. Transgenic over-expression of antioxidant enzymes increases lifespan in mice153–155. Conversely, mice that harbor an error-prone mitochondrial DNA polymerase rapidly accumulate mtDNA mutations and demonstrate multiple aspects of aging, including graying fur, kyphosis, degenerative diseases, and premature death156, 157.
Exercise appears to favorably impact these processes, but the details of how this occurs remain murky. Exercise reduces oxidative damage. Strikingly, endurance exercise reverses nearly all of the aging phenotypes in the “mutator” mice described above, including their multisystem pathology and premature mortality; the mice are nearly indistinguishable from control mice.158 Even more strikingly, exercise prevents accumulation of mtDNA mutations in these “mutator” mice.158 Exercise thus somehow activates systemic mechanisms of mitochondrial quality control, even outside skeletal muscle. There is indeed growing appreciation that exercise induces mitochondrial adaptations in tissues beyond skeletal muscle144, 159–162, and, as noted above, exercise also systemically activates autophagy/mitophagy.
PGC-1α and its powerful regulation by exercise may again play a central role in these processes. PGC-1α simultaneously induces mitochondrial biogenesis and anti-ROS programs.163 Mice that lack PGC-1α accumulate ROS-mediated damage and display dramatically accelerated neuro-degeneration.163 Strikingly, transgenic mice with boosted PGC-1α expression in skeletal muscle have increased longevity and are healthier in old age.164 As noted above, these transgenic mice recapitulate many aspects of endurance exercise adaptations, but they are not more active at baseline. Boosting PGC-1α only in skeletal muscle is thus sufficient to prolong life in rodents. The same approach does not rescue premature aging in mtDNA “mutator” mice, which suggests either a threshold effect or more unappreciated complexity.165 Overall, these observations again point to the powerful influence of muscle on the rest of the body, and again suggest the existence of organ crosstalk via myokines. The existence of circulating “rejuvenating” factors has been supported by parabiosis experiments (see above for description of the approach): old animals in young-old heterochronic parabiotic pairs reacquire numerous attributes of youth, including tissue and stem cell regenerative potential.166, 167
Telomeres are nucleoprotein complexes at chromosome ends that preserve chromosomal integrity168, 169. The telomere theory of aging holds that cell divisions causes progressive telomere attrition, culminating in activation of p53, the ‘guardian of the genome’, leading to cellular apoptosis and senescence170. Stem cells, which are hyper-proliferative, are especially prone to telomere erosion. Loss of resident stem cells impairs turnover and repair capacity of tissues and slowly leads to tissue degeneration. Short telomeres in human peripheral blood leukocytes correlates with higher mortality rates in individuals more than 60 years old171, and telomere length predicts good health and longevity in centenarians and their offspring.172 Telomeres are kept from eroding by the enzyme telomerase168, 169. Mice with dysfunctional telomerase develop numerous accelerated aging phenotypes, supporting the telomere theory of aging. Similarly, mice engineered with hyper-active p53 alleles also display premature aging173. Exercise appears to favorably impact these processes as well, but again the mechanisms are not clear. Exercise activates telomerase and inhibits telomere erosion in circulating cells in mice and humans.174 Recent data have also indicated that telomere shortening and p53 activation leads to repression of PGC-1α and mitochondrial capacity.175 This observation links theories of aging, and suggests that activation of PGC-1α by exercise may thus interfere with aging at this level as well.
In summary, exercise undeniably attenuates the aging process. Early indications are that common, central mechanisms underlie aging in differing tissues, and that exercise may target these key pathways. Longevity and physical inactivity are both on the rise in the industrial world. Studies probing into the mechanisms by which exercise influences aging thus represent one of the most exciting frontiers of exercise research.
Exercise in a pill – is it a dream?
Finding a “gymnomimetic” pill that fully recapitulates exercise is likely an impossible dream. The sheer complexity and pleitropic effects of exercise almost certainly preclude such a simple approach. Nevertheless, understanding the numerous molecular pathways modulated by exercise may enlighten approaches to mimic individual effects of exercise. Pharmacologic activation of AMPK or SIRT in mice, for example, recapitulates certain aspects of exercise, including increases in exercise capacity.176, 177 Activating individual effects of exercise could, for example, serve as adjunct treatment to exercise programs.
The challenges to find even partial exercise mimetics, however, are many. First, the number of potential targets identified so far remains small. Efforts to understand the molecular underpinnings of exercise should thus continue. Second, most of these targets, such as transcription factors or coactivators, are not easily “druggable”. In this light, recent developments with myokines are particularly exciting, because circulating and extracellular factors provide more readily accessible pharmaceutical targets. Early developments with miRNAs also hold promise in this context, because miRNAs are proving to be readily targeted in humans with antiMirs and miRNA analogs. And third, because gymnomimetics would likely be used for prevention or chronic treatment, safety profiles would need to be nearly perfect. This is a serious problem, because exercise by its nature has pleitropic effects, which is generally not ideal for a pharmaceutical agent. In this last context, initial proof-of-concept therapeutic efforts may have more success by targeting patient populations with few other options, because such patients would more likely be willing to accept adverse side effects. For example, genetic induction of PGC-1α in muscle in mice reduces degeneration in a murine model of Duchene Muscle Dystrophy.178 Lastly, the gymnomimetic field is also muddled by contrasting goals. Whereas many look to exercise for mechanistic insight into disease prevention, many in the sporting arena seek performance-enhancement.
In short, although the physiology of exercise has been investigated for centuries, the molecular biology of exercise remains a young science. The translation of molecular findings to therapeutics so far remains more of a promise than a reality.
Conclusions
Interest in exercise predates written history. This interest has been brought to the fore of modern medical attention by rising physical inactivity, and the attendant ill effects on population health. New molecular and genetic tools have allowed probing over the past 10 years into the molecular mechanisms of responses to physical activity. A large part of this work has relied on access to genetically modified mice, for two reasons: genetic modifications provide precise experimental scalpels with which to probe complex pathways; and rodents provide a tractable and at least partly faithful model of the complexities of exercise in humans. A rising theme from this body of work has been that exercise activates systemic inter-cellular and inter-organ communication via the secretion of factors from skeletal muscle and elsewhere. Much of the health benefits of exercise likely depend on these messengers. The potential good news is that circulating factors are often tractable therapeutic targets.
These advances, however, represent only the first steps of the marathon. Numerous critical questions remain unanswered, including the precise molecular causes of fatigue, the detailed mechanisms of muscle adaptations, how the will to exercise is conjured, and the identity and function of the panoply of myokines and agents of organ cross talk. Exercise is perhaps the most potent intervention in our arsenal to prevent cardiovascular disease. We are running ahead in the race to understand the complexity of exercise. Using that knowledge to derive novel interventions for cardiovascular disease would represent a formidable finish line.
Supplementary Material
Acknowledgments
We thank Kristin Johnson for artwork.
Funding Sources: GCR is supported by the NIH (AR062128), AS is supported by a Banting Fellowship, and ZA is supported by the NIH (HL094499).
Footnotes
Conflict of Interest Disclosures: None
References
- 1.Morris JN, Heady JA, Raffle PA, Roberts CG, Parks JW. Coronary heart-disease and physical activity of work. Lancet. 1953;265:1053–1057. doi: 10.1016/s0140-6736(53)90665-5. contd. [DOI] [PubMed] [Google Scholar]
- 2.Morris JN, Heady JA, Raffle PA, Roberts CG, Parks JW. Coronary heart-disease and physical activity of work. Lancet. 1953;265:1111–1120. doi: 10.1016/s0140-6736(53)91495-0. concl. [DOI] [PubMed] [Google Scholar]
- 3.Bramble DM, Lieberman DE. Endurance running and the evolution of homo. Nature. 2004;432:345–352. doi: 10.1038/nature03052. [DOI] [PubMed] [Google Scholar]
- 4.Ruxton GD, Wilkinson DM. Thermoregulation and endurance running in extinct hominins: Wheeler's models revisited. J Hum Evol. 2011;61:169–175. doi: 10.1016/j.jhevol.2011.02.012. [DOI] [PubMed] [Google Scholar]
- 5.Jablonski NG, Chaplin G. The evolution of human skin coloration. J Hum Evol. 2000;39:57–106. doi: 10.1006/jhev.2000.0403. [DOI] [PubMed] [Google Scholar]
- 6.Egan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab. 2013;17:162–184. doi: 10.1016/j.cmet.2012.12.012. [DOI] [PubMed] [Google Scholar]
- 7.Coffey VG, Hawley JA. The molecular bases of training adaptation. Sports Med. 2007;37:737–763. doi: 10.2165/00007256-200737090-00001. [DOI] [PubMed] [Google Scholar]
- 8.Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012;2:1143–1211. doi: 10.1002/cphy.c110025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Schiaffino S, Sandri M, Murgia M. Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 2007;22:269–278. doi: 10.1152/physiol.00009.2007. [DOI] [PubMed] [Google Scholar]
- 10.Stuart CA, McCurry MP, Marino A, South MA, Howell ME, Layne AS, Ramsey MW, Stone MH. Slow-twitch fiber proportion in skeletal muscle correlates with insulin responsiveness. J Clin Endocrinol Metab. 2013;98:2027–2036. doi: 10.1210/jc.2012-3876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hambrecht R, Fiehn E, Yu J, Niebauer J, Weigl C, Hilbrich L, Adams V, Riede U, Schuler G. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol. 1997;29:1067–1073. doi: 10.1016/s0735-1097(97)00015-6. [DOI] [PubMed] [Google Scholar]
- 12.Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM. Transcriptional co-activator pgc-1 alpha drives the formation of slow-twitch muscle fibres. Nature. 2002;418:797–801. doi: 10.1038/nature00904. [DOI] [PubMed] [Google Scholar]
- 13.Calvo JA, Daniels TG, Wang X, Paul A, Lin J, Spiegelman BM, Stevenson SC, Rangwala SM. Muscle-specific expression of ppar{gamma} coactivator-1{alpha} improves exercise performance and increases peak oxygen uptake. J Appl Physiol. 2008;104:1304–1312. doi: 10.1152/japplphysiol.01231.2007. [DOI] [PubMed] [Google Scholar]
- 14.Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, Ma Y, Chin S, Spiegelman BM. The transcriptional coactivator pgc-1beta drives the formation of oxidative type iix fibers in skeletal muscle. Cell Metab. 2007;5:35–46. doi: 10.1016/j.cmet.2006.12.003. [DOI] [PubMed] [Google Scholar]
- 15.Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, Grimaldi PA. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J. 2003;17:2299–2301. doi: 10.1096/fj.03-0269fje. [DOI] [PubMed] [Google Scholar]
- 16.Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM. Regulation of muscle fiber type and running endurance by ppardelta. PLoS Biol. 2004;2:e294. doi: 10.1371/journal.pbio.0020294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Seth A, Steel JH, Nichol D, Pocock V, Kumaran MK, Fritah A, Mobberley M, Ryder TA, Rowlerson A, Scott J, Poutanen M, White R, Parker M. The transcriptional corepressor rip140 regulates oxidative metabolism in skeletal muscle. Cell Metab. 2007;6:236–245. doi: 10.1016/j.cmet.2007.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Naya FJ, Mercer B, Shelton J, Richardson JA, Williams RS, Olson EN. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. J Biol Chem. 2000;275:4545–4548. doi: 10.1074/jbc.275.7.4545. [DOI] [PubMed] [Google Scholar]
- 19.Hasumi H, Baba M, Hasumi Y, Huang Y, Oh H, Hughes RM, Klein ME, Takikita S, Nagashima K, Schmidt LS, Linehan WM. Regulation of mitochondrial oxidative metabolism by tumor suppressor flcn. J Natl Cancer Inst. 2012;104:1750–1764. doi: 10.1093/jnci/djs418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, McAnally J, Richardson JA, Bassel-Duby R, Olson EN. Histone deacetylase degradation and mef2 activation promote the formation of slow-twitch myofibers. J Clin Invest. 2007;117:2459–2467. doi: 10.1172/JCI31960. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Quinn LS, Anderson BG, Conner JD, Wolden-Hanson T. Il-15 overexpression promotes endurance, oxidative energy metabolism, and muscle ppardelta, sirt1, pgc-1alpha, and pgc-1beta expression in male mice. Endocrinology. 2013;154:232–245. doi: 10.1210/en.2012-1773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Chao LC, Wroblewski K, Ilkayeva OR, Stevens RD, Bain J, Meyer GA, Schenk S, Martinez L, Vergnes L, Narkar VA, Drew BG, Hong C, Boyadjian R, Hevener AL, Evans RM, Reue K, Spencer MJ, Newgard CB, Tontonoz P. Skeletal muscle nur77 expression enhances oxidative metabolism and substrate utilization. J Lipid Res. 2012;53:2610–2619. doi: 10.1194/jlr.M029355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Casas F, Pessemesse L, Grandemange S, Seyer P, Gueguen N, Baris O, Lepourry L, Cabello G, Wrutniak-Cabello C. Overexpression of the mitochondrial t3 receptor p43 induces a shift in skeletal muscle fiber types. PloS one. 2008;3:e2501. doi: 10.1371/journal.pone.0002501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hakimi P, Yang J, Casadesus G, Massillon D, Tolentino-Silva F, Nye CK, Cabrera ME, Hagen DR, Utter CB, Baghdy Y, Johnson DH, Wilson DL, Kirwan JP, Kalhan SC, Hanson RW. Overexpression of the cytosolic form of phosphoenolpyruvate carboxykinase (gtp) in skeletal muscle repatterns energy metabolism in the mouse. J Biol Chem. 2007;282:32844–32855. doi: 10.1074/jbc.M706127200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Scime A, Soleimani VD, Bentzinger CF, Gillespie MA, Le Grand F, Grenier G, Bevilacqua L, Harper ME, Rudnicki MA. Oxidative status of muscle is determined by p107 regulation of pgc-1alpha. J Cell Biol. 2010;190:651–662. doi: 10.1083/jcb.201005076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Voltarelli VA, Bacurau AV, Bechara LR, Bueno CR, Jr, Bozi LH, Mattos KC, Salemi VM, Brum PC. Lack of beta2-ar improves exercise capacity and skeletal muscle oxidative phenotype in mice. Scand J Med Sci Sports. 2012;22:e125–e132. doi: 10.1111/j.1600-0838.2012.01519.x. [DOI] [PubMed] [Google Scholar]
- 27.Yamamoto H, Williams EG, Mouchiroud L, Canto C, Fan W, Downes M, Heligon C, Barish GD, Desvergne B, Evans RM, Schoonjans K, Auwerx J. Ncor1 is a conserved physiological modulator of muscle mass and oxidative function. Cell. 2011;147:827–839. doi: 10.1016/j.cell.2011.10.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Pistilli EE, Bogdanovich S, Garton F, Yang N, Gulbin JP, Conner JD, Anderson BG, Quinn LS, North K, Ahima RS, Khurana TS. Loss of il-15 receptor alpha alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles. J Clin Invest. 2011;121:3120–3132. doi: 10.1172/JCI44945. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wu H, Kanatous SB, Thurmond FA, Gallardo T, Isotani E, Bassel-Duby R, Williams RS. Regulation of mitochondrial biogenesis in skeletal muscle by camk. Science. 2002;296:349–352. doi: 10.1126/science.1071163. [DOI] [PubMed] [Google Scholar]
- 30.Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, Rosenberg PB, Williams RS, Yan Z. Exercise stimulates pgc-1alpha transcription in skeletal muscle through activation of the p38 mapk pathway. J Biol Chem. 2005;280:19587–19593. doi: 10.1074/jbc.M408862200. [DOI] [PubMed] [Google Scholar]
- 31.Parsons SA, Wilkins BJ, Bueno OF, Molkentin JD. Altered skeletal muscle phenotypes in calcineurin aalpha and abeta gene-targeted mice. Mol Cell Biol. 2003;23:4331–4343. doi: 10.1128/MCB.23.12.4331-4343.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Bassel-Duby R, Olson EN. Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem. 2006;75:19–37. doi: 10.1146/annurev.biochem.75.103004.142622. [DOI] [PubMed] [Google Scholar]
- 33.Kramerova I, Kudryashova E, Ermolova N, Saenz A, Jaka O, Lopez de Munain A, Spencer MJ. Impaired calcium calmodulin kinase signaling and muscle adaptation response in the absence of calpain 3. Hum Mol Genet. 2012;21:3193–3204. doi: 10.1093/hmg/dds144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Pogozelski AR, Geng T, Li P, Yin X, Lira VA, Zhang M, Chi JT, Yan Z. P38gamma mitogen-activated protein kinase is a key regulator in skeletal muscle metabolic adaptation in mice. PloS one. 2009;4:e7934. doi: 10.1371/journal.pone.0007934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Grimm M, Brown JH. Beta-adrenergic receptor signaling in the heart: Role of camkii. J Mol Cell Cardiol. 2010;48:322–330. doi: 10.1016/j.yjmcc.2009.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.O'Neill HM, Maarbjerg SJ, Crane JD, Jeppesen J, Jorgensen SB, Schertzer JD, Shyroka O, Kiens B, van Denderen BJ, Tarnopolsky MA, Kemp BE, Richter EA, Steinberg GR. Amp-activated protein kinase (ampk) beta1beta2 muscle null mice reveal an essential role for ampk in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci U S A. 2011;108:16092–16097. doi: 10.1073/pnas.1105062108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Garcia-Roves PM, Osler ME, Holmstrom MH, Zierath JR. Gain-of-function r225q mutation in amp-activated protein kinase gamma3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J Biol Chem. 2008;283:35724–35734. doi: 10.1074/jbc.M805078200. [DOI] [PubMed] [Google Scholar]
- 38.Barnes BR, Marklund S, Steiler TL, Walter M, Hjalm G, Amarger V, Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M, Stapleton D, Zierath JR, Andersson L. The 5'-amp-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem. 2004;279:38441–38447. doi: 10.1074/jbc.M405533200. [DOI] [PubMed] [Google Scholar]
- 39.Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J. Ampk regulates energy expenditure by modulating nad+ metabolism and sirt1 activity. Nature. 2009;458:1056–1060. doi: 10.1038/nature07813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Richardson RS, Noyszewski EA, Kendrick KF, Leigh JS, Wagner PD. Myoglobin o2 desaturation during exercise. Evidence of limited o2 transport. J Clin Invest. 1995;96:1916–1926. doi: 10.1172/JCI118237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Mason SD, Howlett RA, Kim MJ, Olfert IM, Hogan MC, McNulty W, Hickey RP, Wagner PD, Kahn CR, Giordano FJ, Johnson RS. Loss of skeletal muscle hif-1alpha results in altered exercise endurance. PLoS Biol. 2004;2:e288. doi: 10.1371/journal.pbio.0020288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Mason SD, Rundqvist H, Papandreou I, Duh R, McNulty WJ, Howlett RA, Olfert IM, Sundberg CJ, Denko NC, Poellinger L, Johnson RS. Hif-1alpha in endurance training: Suppression of oxidative metabolism. Am J Physiol Regul Integr Comp Physiol. 2007;293:R2059–R2069. doi: 10.1152/ajpregu.00335.2007. [DOI] [PubMed] [Google Scholar]
- 43.Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev. 2006;27:728–735. doi: 10.1210/er.2006-0037. [DOI] [PubMed] [Google Scholar]
- 44.Zechner C, Lai L, Zechner JF, Geng T, Yan Z, Rumsey JW, Collia D, Chen Z, Wozniak DF, Leone TC, Kelly DP. Total skeletal muscle pgc-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab. 2011;12:633–642. doi: 10.1016/j.cmet.2010.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rowe GC, Patten IS, Zsengeller ZK, El-Khoury R, Okutsu M, Bampoh S, Koulisis N, Farrell C, Hirshman MF, Yan Z, Goodyear LJ, Rustin P, Arany Z. Disconnecting mitochondrial content from respiratory chain capacity in pgc-1-deficient skeletal muscle. Cell reports. 2013;3:1449–1456. doi: 10.1016/j.celrep.2013.04.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Rowe GC, Jiang A, Arany Z. Pgc-1 coactivators in cardiac development and disease. Circ Res. 2011;107:825–838. doi: 10.1161/CIRCRESAHA.110.223818. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Madrazo JA, Kelly DP. The ppar trio: Regulators of myocardial energy metabolism in health and disease. J Mol Cell Cardiol. 2008;44:968–975. doi: 10.1016/j.yjmcc.2008.03.021. [DOI] [PubMed] [Google Scholar]
- 48.Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev. 2008;88:611–638. doi: 10.1152/physrev.00025.2007. [DOI] [PubMed] [Google Scholar]
- 49.Long YC, Zierath JR. Amp-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006;116:1776–1783. doi: 10.1172/JCI29044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Winder WW, Taylor EB, Thomson DM. Role of amp-activated protein kinase in the molecular adaptation to endurance exercise. Med Sci Sports Exerc. 2006;38:1945–1949. doi: 10.1249/01.mss.0000233798.62153.50. [DOI] [PubMed] [Google Scholar]
- 51.Barres R, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, Caidahl K, Krook A, O'Gorman DJ, Zierath JR. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 2012;15:405–411. doi: 10.1016/j.cmet.2012.01.001. [DOI] [PubMed] [Google Scholar]
- 52.van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ, Jr, Olson EN. A family of micrornas encoded by myosin genes governs myosin expression and muscle performance. Dev Cell. 2009;17:662–673. doi: 10.1016/j.devcel.2009.10.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Safdar A, Abadi A, Akhtar M, Hettinga BP, Tarnopolsky MA. Mirna in the regulation of skeletal muscle adaptation to acute endurance exercise in c57bl/6j male mice. PloS One. 2009;4:e5610. doi: 10.1371/journal.pone.0005610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Baggish AL, Hale A, Weiner RB, Lewis GD, Systrom D, Wang F, Wang TJ, Chan SY. Dynamic regulation of circulating microrna during acute exhaustive exercise and sustained aerobic exercise training. J Physiol. 2011;589:3983–3994. doi: 10.1113/jphysiol.2011.213363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Hyde BB, Twig G, Shirihai OS. Organellar vs cellular control of mitochondrial dynamics. Semin Cell Dev Biol. 2010;21:575–581. doi: 10.1016/j.semcdb.2010.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Chan DC. Fusion and fission: Interlinked processes critical for mitochondrial health. Annu Rev Genet. 2012;46:265–287. doi: 10.1146/annurev-genet-110410-132529. [DOI] [PubMed] [Google Scholar]
- 57.Kirkwood SP, Packer L, Brooks GA. Effects of endurance training on a mitochondrial reticulum in limb skeletal muscle. Arch Biochem Biophys. 1987;255:80–88. doi: 10.1016/0003-9861(87)90296-7. [DOI] [PubMed] [Google Scholar]
- 58.Twig G, Shirihai OS. The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal. 2011;14:1939–1951. doi: 10.1089/ars.2010.3779. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Ding H, Jiang N, Liu H, Liu X, Liu D, Zhao F, Wen L, Liu S, Ji LL, Zhang Y. Response of mitochondrial fusion and fission protein gene expression to exercise in rat skeletal muscle. Biochim Biophys Acta. 2010;1800:250–256. doi: 10.1016/j.bbagen.2009.08.007. [DOI] [PubMed] [Google Scholar]
- 60.Cartoni R, Leger B, Hock MB, Praz M, Crettenand A, Pich S, Ziltener JL, Luthi F, Deriaz O, Zorzano A, Gobelet C, Kralli A, Russell AP. Mitofusins 1/2 and erralpha expression are increased in human skeletal muscle after physical exercise. J Physiol. 2005;567:349–358. doi: 10.1113/jphysiol.2005.092031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Perry CG, Lally J, Holloway GP, Heigenhauser GJ, Bonen A, Spriet LL. Repeated transient mrna bursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle. J Physiol. 2010;588:4795–4810. doi: 10.1113/jphysiol.2010.199448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM, Chan DC. Mitochondrial fusion is required for mtdna stability in skeletal muscle and tolerance of mtdna mutations. Cell. 2010;141:280–289. doi: 10.1016/j.cell.2010.02.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Mizushima N, Komatsu M. Autophagy: Renovation of cells and tissues. Cell. 2011;147:728–741. doi: 10.1016/j.cell.2011.10.026. [DOI] [PubMed] [Google Scholar]
- 64.Grumati P, Coletto L, Schiavinato A, Castagnaro S, Bertaggia E, Sandri M, Bonaldo P. Physical exercise stimulates autophagy in normal skeletal muscles but is detrimental for collagen vi-deficient muscles. Autophagy. 2011;7:1415–1423. doi: 10.4161/auto.7.12.17877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.He C, Bassik MC, Moresi V, Sun K, Wei Y, Zou Z, An Z, Loh J, Fisher J, Sun Q, Korsmeyer S, Packer M, May HI, Hill JA, Virgin HW, Gilpin C, Xiao G, Bassel-Duby R, Scherer PE, Levine B. Exercise-induced bcl2-regulated autophagy is required for muscle glucose homeostasis. Nature. 2012;481:511–515. doi: 10.1038/nature10758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.He C, Sumpter R, Jr, Levine B. Exercise induces autophagy in peripheral tissues and in the brain. Autophagy. 2012;8:1548–1551. doi: 10.4161/auto.21327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Smuder AJ, Kavazis AN, Min K, Powers SK. Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle. J Appl Physiol. 2011;111:1190–1198. doi: 10.1152/japplphysiol.00429.2011. [DOI] [PubMed] [Google Scholar]
- 68.Wu J, Ruas JL, Estall JL, Rasbach KA, Choi JH, Ye L, Bostrom P, Tyra HM, Crawford RW, Campbell KP, Rutkowski DT, Kaufman RJ, Spiegelman BM. The unfolded protein response mediates adaptation to exercise in skeletal muscle through a pgc-1alpha/atf6alpha complex. Cell Metab. 2011;13:160–169. doi: 10.1016/j.cmet.2011.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Zwetsloot KA, Westerkamp LM, Holmes BF, Gavin TP. Ampk regulates basal skeletal muscle capillarization and vegf expression, but is not necessary for the angiogenic response to exercise. J Physiol. 2008;586:6021–6035. doi: 10.1113/jphysiol.2008.159871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Chinsomboon J, Ruas J, Gupta RK, Thom R, Shoag J, Rowe GC, Sawada N, Raghuram S, Arany Z. The transcriptional coactivator pgc-1{alpha} mediates exercise-induced angiogenesis in skeletal muscle. Proc Natl Acad Sci U S A. 2009;106:21401–21406. doi: 10.1073/pnas.0909131106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Rowe GC, El-Khoury R, Patten IS, Rustin P, Arany Z. Pgc-1alpha is dispensable for exercise-induced mitochondrial biogenesis in skeletal muscle. PloS One. 2012;7:e41817. doi: 10.1371/journal.pone.0041817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Leick L, Wojtaszewski JF, Johansen ST, Kiilerich K, Comes G, Hellsten Y, Hidalgo J, Pilegaard H. Pgc-1alpha is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle. Am J Physiol Endocrinol Metab. 2008;294:E463–E474. doi: 10.1152/ajpendo.00666.2007. [DOI] [PubMed] [Google Scholar]
- 73.Arany Z, Foo S-Y, Ma Y, Ruas J, Bommi-Reddy A, Girnun GD, Cooper M, Laznik D, Chinsomboon J, Rangwala S, Baek K-H, Rosenzweig A, Spiegelman B. Hif-independent regulation of vegf and angiogenesis by the transcriptional coactivator pgc-1α. Nature. 2008;451:1008–1012. doi: 10.1038/nature06613. [DOI] [PubMed] [Google Scholar]
- 74.Pedersen BK, Febbraio MA. Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8:457–465. doi: 10.1038/nrendo.2012.49. [DOI] [PubMed] [Google Scholar]
- 75.Pedersen BK, Febbraio MA. Muscle as an endocrine organ: Focus on muscle-derived interleukin-6. Physiol Rev. 2008;88:1379–1406. doi: 10.1152/physrev.90100.2007. [DOI] [PubMed] [Google Scholar]
- 76.Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G, Prelovsek O, Hohnen-Behrens C, Watt MJ, James DE, Kemp BE, Pedersen BK, Febbraio MA. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via amp-activated protein kinase. Diabetes. 2006;55:2688–2697. doi: 10.2337/db05-1404. [DOI] [PubMed] [Google Scholar]
- 77.Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, Eppler E, Bouzakri K, Wueest S, Muller YD, Hansen AM, Reinecke M, Konrad D, Gassmann M, Reimann F, Halban PA, Gromada J, Drucker DJ, Gribble FM, Ehses JA, Donath MY. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from l cells and alpha cells. Nat Med. 2011;17:1481–1489. doi: 10.1038/nm.2513. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med. 2002;8:75–79. doi: 10.1038/nm0102-75. [DOI] [PubMed] [Google Scholar]
- 79.Abbas T, Faivre E, Holscher C. Impairment of synaptic plasticity and memory formation in glp-1 receptor ko mice: Interaction between type 2 diabetes and alzheimer's disease. Behav Brain Res. 2009;205:265–271. doi: 10.1016/j.bbr.2009.06.035. [DOI] [PubMed] [Google Scholar]
- 80.Isacson R, Nielsen E, Dannaeus K, Bertilsson G, Patrone C, Zachrisson O, Wikstrom L. The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test. Eur J Pharmacol. 2011;650:249–255. doi: 10.1016/j.ejphar.2010.10.008. [DOI] [PubMed] [Google Scholar]
- 81.Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM. A pgc1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 481:463–468. doi: 10.1038/nature10777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Lecker SH, Zavin A, Cao P, Arena R, Allsup K, Daniels KM, Joseph J, Schulze PC, Forman DE. Expression of the irisin precursor fndc5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ Heart Fail. 2012;5:812–818. doi: 10.1161/CIRCHEARTFAILURE.112.969543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Timmons JA, Baar K, Davidsen PK, Atherton PJ. Is irisin a human exercise gene? Nature. 2012;488:E9–E10. doi: 10.1038/nature11364. discussion E10-11. [DOI] [PubMed] [Google Scholar]
- 84.Shan T, Liang X, Bi P, Kuang S. Myostatin knockout drives browning of white adipose tissue through activating the ampk-pgc1alpha-fndc5 pathway in muscle. FASEB J. 2013;27:1981–1989. doi: 10.1096/fj.12-225755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Izumiya Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A, Walsh K. Fgf21 is an akt-regulated myokine. FEBS Lett. 2008;582:3805–3810. doi: 10.1016/j.febslet.2008.10.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Kim KH, Jeong YT, Oh H, Kim SH, Cho JM, Kim YN, Kim SS, Kim do H, Hur KY, Kim HK, Ko T, Han J, Kim HL, Kim J, Back SH, Komatsu M, Chen H, Chan DC, Konishi M, Itoh N, Choi CS, Lee MS. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing fgf21 as a mitokine. Nat Med. 2012;19:83–92. doi: 10.1038/nm.3014. [DOI] [PubMed] [Google Scholar]
- 87.Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GW. Myonectin (ctrp15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem. 2012;287:11968–11980. doi: 10.1074/jbc.M111.336834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Guma A, Martinez-Redondo V, Lopez-Soldado I, Canto C, Zorzano A. Emerging role of neuregulin as a modulator of muscle metabolism. Am J Physiol Endocrinol Metab. 2010;298:E742–E750. doi: 10.1152/ajpendo.00541.2009. [DOI] [PubMed] [Google Scholar]
- 89.Broholm C, Laye MJ, Brandt C, Vadalasetty R, Pilegaard H, Pedersen BK, Scheele C. Lif is a contraction-induced myokine stimulating human myocyte proliferation. J Appl Physiol. 2011;111:251–259. doi: 10.1152/japplphysiol.01399.2010. [DOI] [PubMed] [Google Scholar]
- 90.Matthews VB, Astrom MB, Chan MH, Bruce CR, Krabbe KS, Prelovsek O, Akerstrom T, Yfanti C, Broholm C, Mortensen OH, Penkowa M, Hojman P, Zankari A, Watt MJ, Bruunsgaard H, Pedersen BK, Febbraio MA. Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of amp-activated protein kinase. Diabetologia. 2009;52:1409–1418. doi: 10.1007/s00125-009-1364-1. [DOI] [PubMed] [Google Scholar]
- 91.Lewis GD, Farrell L, Wood MJ, Martinovic M, Arany Z, Rowe GC, Souza A, Cheng S, McCabe EL, Yang E, Shi X, Deo R, Roth FP, Asnani A, Rhee EP, Systrom DM, Semigran MJ, Vasan RS, Carr SA, Wang TJ, Sabatine MS, Clish CB, Gerszten RE. Metabolic signatures of exercise in human plasma. Sci Transl Med. 2011;2:33ra37. doi: 10.1126/scitranslmed.3001006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, Gao J, Chen JL, Tian H, Ling L. Citric acid cycle intermediates as ligands for orphan g-protein-coupled receptors. Nature. 2004;429:188–193. doi: 10.1038/nature02488. [DOI] [PubMed] [Google Scholar]
- 93.Ahmed K, Tunaru S, Tang C, Muller M, Gille A, Sassmann A, Hanson J, Offermanns S. An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through gpr81. Cell Metab. 2010;11:311–319. doi: 10.1016/j.cmet.2010.02.012. [DOI] [PubMed] [Google Scholar]
- 94.Mann N, Rosenzweig A. Can exercise teach us how to treat heart disease? Circulation. 2012;126:2625–2635. doi: 10.1161/CIRCULATIONAHA.111.060376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.DeMaria AN, Neumann A, Lee G, Fowler W, Mason DT. Alterations in ventricular mass and performance induced by exercise training in man evaluated by echocardiography. Circulation. 1978;57:237–244. doi: 10.1161/01.cir.57.2.237. [DOI] [PubMed] [Google Scholar]
- 96.Hill JA, Olson EN. Cardiac plasticity. N Engl J Med. 2008;358:1370–1380. doi: 10.1056/NEJMra072139. [DOI] [PubMed] [Google Scholar]
- 97.Welch S, Plank D, Witt S, Glascock B, Schaefer E, Chimenti S, Andreoli AM, Limana F, Leri A, Kajstura J, Anversa P, Sussman MA. Cardiac-specific igf-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res. 2002;90:641–648. doi: 10.1161/01.res.0000013780.77774.75. [DOI] [PubMed] [Google Scholar]
- 98.McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, Bisping E, Schinke M, Kong S, Sherwood MC, Brown J, Riggi L, Kang PM, Izumo S. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J Biol Chem. 2004;279:4782–4793. doi: 10.1074/jbc.M310405200. [DOI] [PubMed] [Google Scholar]
- 99.DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, Muslin AJ. Akt1 is required for physiological cardiac growth. Circulation. 2006;113:2097–2104. doi: 10.1161/CIRCULATIONAHA.105.595231. [DOI] [PubMed] [Google Scholar]
- 100.Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, Picard MH, Liao R, Rosenzweig A. Phenotypic spectrum caused by transgenic overexpression of activated akt in the heart. J Biol Chem. 2002;277:22896–22901. doi: 10.1074/jbc.M200347200. [DOI] [PubMed] [Google Scholar]
- 101.Calvert JW, Condit ME, Aragon JP, Nicholson CK, Moody BF, Hood RL, Sindler AL, Gundewar S, Seals DR, Barouch LA, Lefer DJ. Exercise protects against myocardial ischemia-reperfusion injury via stimulation of beta(3)-adrenergic receptors and increased nitric oxide signaling: Role of nitrite and nitrosothiols. Circ Res. 2011;108:1448–1458. doi: 10.1161/CIRCRESAHA.111.241117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Kikuchi K, Holdway JE, Werdich AA, Anderson RM, Fang Y, Egnaczyk GF, Evans T, Macrae CA, Stainier DY, Poss KD. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature. 2010;464:601–605. doi: 10.1038/nature08804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331:1078–1080. doi: 10.1126/science.1200708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Oberpriller JO, Oberpriller JC. Response of the adult newt ventricle to injury. J Exp Zool. 1974;187:249–253. doi: 10.1002/jez.1401870208. [DOI] [PubMed] [Google Scholar]
- 105.Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98–102. doi: 10.1126/science.1164680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Bostrom P, Mann N, Wu J, Quintero PA, Plovie ER, Panakova D, Gupta RK, Xiao C, MacRae CA, Rosenzweig A, Spiegelman BM. C/ebpbeta controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell. 2010;143:1072–1083. doi: 10.1016/j.cell.2010.11.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Gude N, Muraski J, Rubio M, Kajstura J, Schaefer E, Anversa P, Sussman MA. Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res. 2006;99:381–388. doi: 10.1161/01.RES.0000236754.21499.1c. [DOI] [PubMed] [Google Scholar]
- 108.O'Keefe JH, Lavie CJ. Run for your life … At a comfortable speed and not too far. Heart. 2013;99:516–519. doi: 10.1136/heartjnl-2012-302886. [DOI] [PubMed] [Google Scholar]
- 109.Patil HR, O'Keefe JH, Lavie CJ, Magalski A, Vogel RA, McCullough PA. Cardiovascular damage resulting from chronic excessive endurance exercise. Missouri medicine. 2012;109:312–321. [PMC free article] [PubMed] [Google Scholar]
- 110.Volders PG. Marathon rat: Myocardial remodeling in an animal model of vigorous endurance exercise and implications for humans. Circulation. 2011;123:5–7. doi: 10.1161/CIRCULATIONAHA.110.000174. [DOI] [PubMed] [Google Scholar]
- 111.Aizer A, Gaziano JM, Cook NR, Manson JE, Buring JE, Albert CM. Relation of vigorous exercise to risk of atrial fibrillation. Am J Cardiol. 2009;103:1572–1577. doi: 10.1016/j.amjcard.2009.01.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.La Gerche A, Burns AT, Taylor AJ, Macisaac AI, Heidbuchel H, Prior DL. Maximal oxygen consumption is best predicted by measures of cardiac size rather than function in healthy adults. Eur J Appl Physiol. 2012;112:2139–2147. doi: 10.1007/s00421-011-2184-9. [DOI] [PubMed] [Google Scholar]
- 113.Benito B, Gay-Jordi G, Serrano-Mollar A, Guasch E, Shi Y, Tardif JC, Brugada J, Nattel S, Mont L. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation. 2011;123:13–22. doi: 10.1161/CIRCULATIONAHA.110.938282. [DOI] [PubMed] [Google Scholar]
- 114.Gay-Jordi G, Guash E, Benito B, Brugada J, Nattel S, Mont L, Serrano-Mollar A. Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model. PloS one. 2013;8:e55427. doi: 10.1371/journal.pone.0055427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, Secher NH, Pedersen BK, Pilegaard H. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol. 2009;94:1062–1069. doi: 10.1113/expphysiol.2009.048512. [DOI] [PubMed] [Google Scholar]
- 116.Seifert T, Brassard P, Wissenberg M, Rasmussen P, Nordby P, Stallknecht B, Adser H, Jakobsen AH, Pilegaard H, Nielsen HB, Secher NH. Endurance training enhances bdnf release from the human brain. Am J Physiol Regul Integr Comp Physiol. 2012;298:R372–R377. doi: 10.1152/ajpregu.00525.2009. [DOI] [PubMed] [Google Scholar]
- 117.van Praag H, Kempermann G, Gage FH. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci. 1999;2:266–270. doi: 10.1038/6368. [DOI] [PubMed] [Google Scholar]
- 118.Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR, Mailey E, Vieira VJ, Martin SA, Pence BD, Woods JA, McAuley E, Kramer AF. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011;108:3017–3022. doi: 10.1073/pnas.1015950108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Gomez-Pinilla F, Vaynman S, Ying Z. Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition. Eur J Neurosci. 2008;28:2278–2287. doi: 10.1111/j.1460-9568.2008.06524.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Duman CH, Schlesinger L, Russell DS, Duman RS. Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res. 2008;1199:148–158. doi: 10.1016/j.brainres.2007.12.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Steiner JL, Murphy EA, McClellan JL, Carmichael MD, Davis JM. Exercise training increases mitochondrial biogenesis in the brain. J Appl Physiol. 2011;111:1066–1071. doi: 10.1152/japplphysiol.00343.2011. [DOI] [PubMed] [Google Scholar]
- 122.Cheng A, Wan R, Yang JL, Kamimura N, Son TG, Ouyang X, Luo Y, Okun E, Mattson MP. Involvement of pgc-1alpha in the formation and maintenance of neuronal dendritic spines. Nat Commun. 2012;3:1250. doi: 10.1038/ncomms2238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Llorens-Martin M, Torres-Aleman I, Trejo JL. Mechanisms mediating brain plasticity: Igf1 and adult hippocampal neurogenesis. Neuroscientist. 2009;15:134–148. doi: 10.1177/1073858408331371. [DOI] [PubMed] [Google Scholar]
- 124.Huang GJ, Ben-David E, Tort Piella A, Edwards A, Flint J, Shifman S. Neurogenomic evidence for a shared mechanism of the antidepressant effects of exercise and chronic fluoxetine in mice. PloS one. 2012;7:e35901. doi: 10.1371/journal.pone.0035901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Hunsberger JG, Newton SS, Bennett AH, Duman CH, Russell DS, Salton SR, Duman RS. Antidepressant actions of the exercise-regulated gene vgf. Nat Med. 2007;13:1476–1482. doi: 10.1038/nm1669. [DOI] [PubMed] [Google Scholar]
- 126.Moon HY, Kim SH, Yang YR, Song P, Yu HS, Park HG, Hwang O, Lee-Kwon W, Seo JK, Hwang D, Choi JH, Bucala R, Ryu SH, Kim YS, Suh PG. Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise. Proc Natl Acad Sci U S A. 2012;109:13094–13099. doi: 10.1073/pnas.1205535109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Despres S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011;477:90–94. doi: 10.1038/nature10357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Choi KM, Kim JH, Cho GJ, Baik SH, Park HS, Kim SM. Effect of exercise training on plasma visfatin and eotaxin levels. Eur J Endocrinol. 2007;157:437–442. doi: 10.1530/EJE-07-0127. [DOI] [PubMed] [Google Scholar]
- 129.Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS. Environmental enrichment reduces abeta levels and amyloid deposition in transgenic mice. Cell. 2005;120:701–713. doi: 10.1016/j.cell.2005.01.015. [DOI] [PubMed] [Google Scholar]
- 130.Lau YS, Patki G, Das-Panja K, Le WD, Ahmad SO. Neuroprotective effects and mechanisms of exercise in a chronic mouse model of parkinson's disease with moderate neurodegeneration. Eur J Neurosci. 2011;33:1264–1274. doi: 10.1111/j.1460-9568.2011.07626.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Gerecke KM, Jiao Y, Pagala V, Smeyne RJ. Exercise does not protect against mptp-induced neurotoxicity in bdnf happloinsufficent mice. PloS one. 2012;7:e43250. doi: 10.1371/journal.pone.0043250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Fryer JD, Yu P, Kang H, Mandel-Brehm C, Carter AN, Crespo-Barreto J, Gao Y, Flora A, Shaw C, Orr HT, Zoghbi HY. Exercise and genetic rescue of sca1 via the transcriptional repressor capicua. Science. 2012;334:690–693. doi: 10.1126/science.1212673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Koch LG, Kemi OJ, Qi N, Leng SX, Bijma P, Gilligan LJ, Wilkinson JE, Wisloff H, Hoydal MA, Rolim N, Abadir PM, van Grevenhof EM, Smith GL, Burant CF, Ellingsen O, Britton SL, Wisloff U. Intrinsic aerobic capacity sets a divide for aging and longevity. Circ Res. 2011;109:1162–1172. doi: 10.1161/CIRCRESAHA.111.253807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Swallow JG, Carter PA, Garland T., Jr Artificial selection for increased wheel-running behavior in house mice. Behav Genet. 1998;28:227–237. doi: 10.1023/a:1021479331779. [DOI] [PubMed] [Google Scholar]
- 135.Lightfoot JT, Turner MJ, Pomp D, Kleeberger SR, Leamy LJ. Quantitative trait loci for physical activity traits in mice. Physiol Genomics. 2008;32:401–408. doi: 10.1152/physiolgenomics.00241.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Houle-Leroy P, Garland T, Jr, Swallow JG, Guderley H. Effects of voluntary activity and genetic selection on muscle metabolic capacities in house mice mus domesticus. J Appl Physiol. 2000;89:1608–1616. doi: 10.1152/jappl.2000.89.4.1608. [DOI] [PubMed] [Google Scholar]
- 137.Vaanholt LM, Speakman JR, Garland T, Jr, Lobley GE, Visser GH. Protein synthesis and antioxidant capacity in aging mice: Effects of long-term voluntary exercise. Physiol Biochem Zool. 2008;81:148–157. doi: 10.1086/525289. [DOI] [PubMed] [Google Scholar]
- 138.Knab AM, Lightfoot JT. Does the difference between physically active and couch potato lie in the dopamine system? Int J Biol Sci. 2010;6:133–150. doi: 10.7150/ijbs.6.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Kotz CM. Integration of feeding and spontaneous physical activity: Role for orexin. Physiol Behav. 2006;88:294–301. doi: 10.1016/j.physbeh.2006.05.031. [DOI] [PubMed] [Google Scholar]
- 140.Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 2001;30:345–354. doi: 10.1016/s0896-6273(01)00293-8. [DOI] [PubMed] [Google Scholar]
- 141.Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793–801. doi: 10.1056/NEJMoa011858. [DOI] [PubMed] [Google Scholar]
- 142.Goraya TY, Jacobsen SJ, Pellikka PA, Miller TD, Khan A, Weston SA, Gersh BJ, Roger VL. Prognostic value of treadmill exercise testing in elderly persons. Ann Intern Med. 2000;132:862–870. doi: 10.7326/0003-4819-132-11-200006060-00003. [DOI] [PubMed] [Google Scholar]
- 143.Chakravarty EF, Hubert HB, Lingala VB, Fries JF. Reduced disability and mortality among aging runners: A 21-year longitudinal study. Arch Intern Med. 2008;168:1638–1646. doi: 10.1001/archinte.168.15.1638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Boveris A, Navarro A. Systemic and mitochondrial adaptive responses to moderate exercise in rodents. Free radical biology & medicine. 2008;44:224–229. doi: 10.1016/j.freeradbiomed.2007.08.015. [DOI] [PubMed] [Google Scholar]
- 145.Holloszy JO. Exercise increases average longevity of female rats despite increased food intake and no growth retardation. J Gerontol. 1993;48:B97–B100. doi: 10.1093/geronj/48.3.b97. [DOI] [PubMed] [Google Scholar]
- 146.Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol. 1956;11:298–300. doi: 10.1093/geronj/11.3.298. [DOI] [PubMed] [Google Scholar]
- 147.Harman D. Free radical theory of aging. Triangle. 1973;12:153–158. [PubMed] [Google Scholar]
- 148.Harman D. The aging process. Proc Natl Acad Sci U S A. 1981;78:7124–7128. doi: 10.1073/pnas.78.11.7124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Harman D. Aging and oxidative stress. J Int Fed Clin Chem. 1998;10:24–27. [PubMed] [Google Scholar]
- 150.Harman D. The free radical theory of aging. Antioxid Redox Signal. 2003;5:557–561. doi: 10.1089/152308603770310202. [DOI] [PubMed] [Google Scholar]
- 151.Harman D. Origin and evolution of the free radical theory of aging: A brief personal history, 1954–2009. Biogerontology. 2009;10:773–781. doi: 10.1007/s10522-009-9234-2. [DOI] [PubMed] [Google Scholar]
- 152.Park CB, Larsson NG. Mitochondrial DNA mutations in disease and aging. J Cell Biol. 2011;193:809–818. doi: 10.1083/jcb.201010024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Ji LL. Exercise at old age: Does it increase or alleviate oxidative stress? Ann N Y Acad Sci. 2001;928:236–247. doi: 10.1111/j.1749-6632.2001.tb05653.x. [DOI] [PubMed] [Google Scholar]
- 154.Dai DF, Santana LF, Vermulst M, Tomazela DM, Emond MJ, MacCoss MJ, Gollahon K, Martin GM, Loeb LA, Ladiges WC, Rabinovitch PS. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation. 2009;119:2789–2797. doi: 10.1161/CIRCULATIONAHA.108.822403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 155.Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, Wallace DC, Rabinovitch PS. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science. 2005;308:1909–1911. doi: 10.1126/science.1106653. [DOI] [PubMed] [Google Scholar]
- 156.Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, Morrow JD, Van Remmen H, Sedivy JM, Yamasoba T, Tanokura M, Weindruch R, Leeuwenburgh C, Prolla TA. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 2005;309:481–484. doi: 10.1126/science.1112125. [DOI] [PubMed] [Google Scholar]
- 157.Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, Tornell J, Jacobs HT, Larsson NG. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004;429:417–423. doi: 10.1038/nature02517. [DOI] [PubMed] [Google Scholar]
- 158.Safdar A, Bourgeois JM, Ogborn DI, Little JP, Hettinga BP, Akhtar M, Thompson JE, Melov S, Mocellin NJ, Kujoth GC, Prolla TA, Tarnopolsky MA. Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtdna mutator mice. Proc Natl Acad Sci U S A. 2011;108:4135–4140. doi: 10.1073/pnas.1019581108. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 159.Sorensen L, Ekstrand M, Silva JP, Lindqvist E, Xu B, Rustin P, Olson L, Larsson NG. Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in milon mice. J Neurosci. 2001;21:8082–8090. doi: 10.1523/JNEUROSCI.21-20-08082.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Sutherland LN, Bomhof MR, Capozzi LC, Basaraba SA, Wright DC. Exercise and adrenaline increase pgc-1{alpha} mrna expression in rat adipose tissue. J Physiol. 2009;587:1607–1617. doi: 10.1113/jphysiol.2008.165464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 161.Booth FW, Laye MJ. The future: Genes, physical activity and health. Acta Physiol (Oxf) 2010;199:549–556. doi: 10.1111/j.1748-1716.2010.02117.x. [DOI] [PubMed] [Google Scholar]
- 162.Dietrich MO, Andrews ZB, Horvath TL. Exercise-induced synaptogenesis in the hippocampus is dependent on ucp2-regulated mitochondrial adaptation. J Neurosci. 2008;28:10766–10771. doi: 10.1523/JNEUROSCI.2744-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM. Suppression of reactive oxygen species and neurodegeneration by the pgc-1 transcriptional coactivators. Cell. 2006;127:397–408. doi: 10.1016/j.cell.2006.09.024. [DOI] [PubMed] [Google Scholar]
- 164.Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. Increased muscle pgc-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A. 2009;106:20405–20410. doi: 10.1073/pnas.0911570106. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 165.Dillon LM, Williams SL, Hida A, Peacock JD, Prolla TA, Lincoln J, Moraes CT. Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtdna mutator mouse. Hum Mol Genet. 2012;21:2288–2297. doi: 10.1093/hmg/dds049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166.Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433:760–764. doi: 10.1038/nature03260. [DOI] [PubMed] [Google Scholar]
- 167.Ruckh JM, Zhao JW, Shadrach JL, van Wijngaarden P, Rao TN, Wagers AJ, Franklin RJ. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell. 2012;10:96–103. doi: 10.1016/j.stem.2011.11.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.Finkel T, Serrano M, Blasco MA. The common biology of cancer and ageing. Nature. 2007;448:767–774. doi: 10.1038/nature05985. [DOI] [PubMed] [Google Scholar]
- 169.Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, Adams AC, Sahin E, Kost-Alimova M, Protopopov A, Cadinanos J, Horner JW, Maratos-Flier E, Depinho RA. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. 2011;469:102–106. doi: 10.1038/nature09603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 170.Vousden KH, Lane DP. P53 in health and disease. Nat Rev Mol Cell Biol. 2007;8:275–283. doi: 10.1038/nrm2147. [DOI] [PubMed] [Google Scholar]
- 171.Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393–395. doi: 10.1016/S0140-6736(03)12384-7. [DOI] [PubMed] [Google Scholar]
- 172.Atzmon G, Cho M, Cawthon RM, Budagov T, Katz M, Yang X, Siegel G, Bergman A, Huffman DM, Schechter CB, Wright WE, Shay JW, Barzilai N, Govindaraju DR, Suh Y. Evolution in health and medicine sackler colloquium: Genetic variation in human telomerase is associated with telomere length in ashkenazi centenarians. Proc Natl Acad Sci U S A. 2010;107 Suppl 1:1710–1717. doi: 10.1073/pnas.0906191106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173.Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A, Donehower LA. P53 mutant mice that display early ageing-associated phenotypes. Nature. 2002;415:45–53. doi: 10.1038/415045a. [DOI] [PubMed] [Google Scholar]
- 174.Werner C, Furster T, Widmann T, Poss J, Roggia C, Hanhoun M, Scharhag J, Buchner N, Meyer T, Kindermann W, Haendeler J, Bohm M, Laufs U. Physical exercise prevents cellular senescence in circulating leukocytes and in the vessel wall. Circulation. 2009;120:2438–2447. doi: 10.1161/CIRCULATIONAHA.109.861005. [DOI] [PubMed] [Google Scholar]
- 175.Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, Cooper M, Kotton D, Fabian AJ, Walkey C, Maser RS, Tonon G, Foerster F, Xiong R, Wang YA, Shukla SA, Jaskelioff M, Martin ES, Heffernan TP, Protopopov A, Ivanova E, Mahoney JE, Kost-Alimova M, Perry SR, Bronson R, Liao R, Mulligan R, Shirihai OS, Chin L, DePinho RA. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470:359–365. doi: 10.1038/nature09787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176.Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, Mihaylova MM, Nelson MC, Zou Y, Juguilon H, Kang H, Shaw RJ, Evans RM. Ampk and ppardelta agonists are exercise mimetics. Cell. 2008;134:405–415. doi: 10.1016/j.cell.2008.06.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating sirt1 and pgc-1alpha. Cell. 2006;127:1109–1122. doi: 10.1016/j.cell.2006.11.013. [DOI] [PubMed] [Google Scholar]
- 178.Handschin C, Kobayashi YM, Chin S, Seale P, Campbell KP, Spiegelman BM. Pgc-1alpha regulates the neuromuscular junction program and ameliorates duchenne muscular dystrophy. Genes Dev. 2007;21:770–783. doi: 10.1101/gad.1525107. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





